Homepage | RMD Open | A leading rheumatology journal from …
网页RMD Open. RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies ...
Authors | RMD Open | A leading rheumatology journal from …
网页RMD Open is an open access journal and levies an Article Processing Charge (APC) of 2,163 GBP (exclusive of VAT for UK and EU authors). The APC for Letters is 1,082 GBP. There are no submission, colour or page charges. There is a 25% discount for articles where the corresponding author has reviewed for RMD Open within the previous 12 months. A 50% discount on the standard APC will apply to ...
Comparative early effectiveness across 14 PsA drugs and 5 classes …
网页1 天前 · Background The psoriatic arthritis (PsA) Observational Study of Persistence of Treatment (PRO-SPIRIT) assesses effectiveness and persistence of real-world PsA treatments. Ixekizumab (IXE) is an interleukin (IL)-17A inhibitor (i) (IL-17Ai), approved for the treatment of adult PsA. Methods The aim of this predefined interim analysis was to report baseline characteristics along with early (3 ...
About | RMD Open | A leading rheumatology journal from EULAR …
网页RMD Open publishes high quality peer-reviewed original research covering the full spectrum of musculoskeletal disorders, rheumatism and connective tissue diseases, including osteoporosis, spine and rehabilitation. Clinical and epidemiological research, basic and translational medicine, interesting clinical cases, and smaller studies that add to ...
Safety, pharmacokinetics, biomarker response and efficacy of …
网页Objectives To evaluate the safety, tolerability, pharmacokinetics (PK), biomarker response and efficacy of E6742 in a phase I/II study in patients with systemic lupus erythematosus (SLE). Methods Two sequential cohorts of patients with SLE were enrolled and randomised to 12 weeks of two times per day treatment with E6742 (100 or 200 mg; n=8 or 9) or placebo (n=9). The primary endpoint was ...
Table of contents | RMD Open
网页Hermine I Brunner, Carlos Abud-Mendoza, Masaaki Mori, Clarissa A Pilkington, Reema Syed, Syuji Takei, Diego O Viola, Richard A Furie, Sandra Navarra, Fengchun Zhang, Damon L Bass, Gina Eriksson, Anne E Hammer, Beulah N Ji, Mohamed Okily, David A Roth, Holly Quasny, Nicolino Ruperto.
Immune responses to mRNA vaccines against SARS-CoV-2 in
网页Background Patients with immune-mediated rheumatic diseases (IMRDs) are commonly treated with immunosuppressors and prone to infections. Recently introduced mRNA SARS-CoV-2 vaccines have demonstrated extraordinary efficacy across all ages. Immunosuppressed patients were excluded from phase III trials with SARS-CoV-2 mRNA vaccines. Aims To fully characterise B-cell and T-cell immune responses ...
网页Gwinnutt M et al. RMD Open 20228:e002167 doi:101136rmdopen2021002167 1 ORIGINAL RESEARCH Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-
Most Read Articles | RMD Open - BMJ
网页2023年11月23日 · 27 February 2024. MRI of shoulder girdle in polymyalgia rheumatica: inflammatory findings and their diagnostic value. Martin Fruth, Lucie Künitz, Philipp Martin-Seidel, Styliani Tsiami, Xenofon Baraliakos. 9 May 2024. An open access rheumatology journal publishing research on rheumatic and musculoskeletal disorders and …
Top cited articles | RMD Open | A leading rheumatology journal …
网页Impact Factor (JCR): 5.1. Citescore: 7.3. More journal metrics. How we get these metrics. *median number of days. Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis Waiting for JAK inhibitor safety data Comparison between idiopathic and VEXAS ...